Clinical Trials Browser

Phase 2/3 × Hydrochlorothiazide × Lymphoid × Clear all

NCT02072330 2014-02-26

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Phase 2/3 Completed

Hypertension, Lymphoma, Follicular